Floatz logo

SARCOCHOLIC ACID C-11

Primary Sclerosing Cholangitis

University of AarhusSmall moleculePhase 1Dormant
CC
44/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
81/ 100

Competitive context

22 Active assets in the Primary Sclerosing Cholangitis cohort.

Asset / SponsorPhaseRating
Vancomycin
Tampere University Hospital
Phase 4BB
URSODEOXYCHOLIC ACID
Assistance Publique - Hôpitaux de Paris
Phase 3BB
Elafibranor
Ipsen
Phase 3B
Aldafermin
NGM Biopharmaceuticals, Inc
Phase 2/3B
cm-101
ChemomAb Ltd.
Phase 2B

View all 50 →

Same molecule, other indications

SARCOCHOLIC ACID C-11 is also rated in:

cholestasisDormant
CC
Indicative ·
47 / 100
View asset →
primary biliary cholangitisDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →